Research takes aim at hypertrophic cardiomyopathy

08/27/2013 | GenomeWeb Daily News (free registration)

The National Heart, Lung, and Blood Institute has granted $14.4 million for the study of hypertrophic cardiomyopathy in an effort to identify the highest-risk patients. The University of Virginia School of Medicine and the University of Oxford will lead the effort, which will examine imaging, genetic and other predictive tools as well as demographics and clinical variables.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL